Kwang Dong Pharmaceutical Co., Ltd.
Kwang Dong Pharmaceutical Co., Ltd. (KRX: 009290) is trading at ₩6,920.00, about ₹499 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, up 0.29% today. Kwang Dong Pharmaceutical is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩6,710.00
Today's high
₩6,950.00
52 week low
₩5,150.00
52 week high
₩12,800.00
009290 opened at ₩6,900.00, closed previously at ₩6,900.00, and has traded between ₩5,150.00 and ₩12,800.00 over the past 52 weeks.
About
Established in Seoul, South Korea, in 1963, Kwang Dong Pharmaceutical Co., Ltd. functions as a diversified healthcare enterprise. The company is actively involved in the development and distribution of an extensive range of pharmaceutical products. This portfolio includes various over-the-counter (OTC) remedies addressing common ailments such as coughs and colds, eye care, liver conditions, mineral deficiencies, vitamin supplementation, circulatory health, and general wellness tonics. Complementing these are its prescription-only (ETC) medicines, which encompass treatments for a broad spectrum of medical needs, including diabetes, cardiovascular disorders, metabolic imbalances, digestive issues, immune system modulation, obesity, genitourinary and anal conditions, neurological and psychiatric disorders, pain and inflammation, infections, and anti-cancer therapies. Beyond pharmaceuticals, Kwang Dong offers health supplements and a diverse selection of beverages, ranging from general consumer drinks to functional and traditional health-focused options. The company also extends its operations to include the management of hospitals and facilitates widespread product distribution through various retail and wholesale channels, including discount stores, television home shopping, and online e-commerce platforms. Furthermore, Kwang Dong Pharmaceutical acts as a comprehensive MRO (Maintenance, Repair, and Operations) service provider, specializing in the procurement of raw materials, intermediate goods, and industrial consumables, with services extending to construction and international sourcing.
Key statistics
Avg. volume
177.86K
Market cap
₩343.65B
P/E Ratio
13.69
Price-to-sales ratio
0.20
Enterprise value
₩469.40B
Free cash flow yield
18.59%
Debt-to-equity ratio
0.47
Return on equity
3.20%
ROIC
2.07%
Beta
0.36
Dividend yield
1.45%
Last dividend
₩100.00
Financial overview
Revenue
₩1.66T
Earnings per share
₩521.00
Free cash flow
₩57.11B
Net profit margin
1.28%
Gross margin
17.61%
EBITDA
₩48.54B
Revenue growth
1.15%
Similar securities
This is not an investment recommendation
Kwang Dong Pharmaceutical for Indian investors
Kwang Dong Pharmaceutical is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Kwang Dong Pharmaceutical for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Kwang Dong Pharmaceutical’s current yield is 1.45%.Dividend tax explained
FAQs
Can I buy Kwang Dong Pharmaceutical on Paasa?
Kwang Dong Pharmaceutical (009290) has been listed on the Korea Exchange since 2019, in the Medical - Pharmaceuticals industry. Kwang Dong Pharmaceutical is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Kwang Dong Pharmaceutical share cost in rupees?
One Kwang Dong Pharmaceutical share is ₩6,920.00 — about ₹499 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Kwang Dong Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Kwang Dong Pharmaceutical shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Kwang Dong Pharmaceutical price.
Does Kwang Dong Pharmaceutical pay a dividend, and how is it taxed in India?
Yes. Kwang Dong Pharmaceutical pays a dividend and the current yield is 1.45%; the last declared dividend was ₩100.00 per share, about ₹7.22. Dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Kwang Dong Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Kwang Dong Pharmaceutical?
Yes. Kwang Dong Pharmaceutical is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.